Provided by Tiger Trade Technology Pte. Ltd.

Unicycive Therapeutics, Inc.

4.78
+0.07001.49%
Post-market: 4.800.0200+0.42%16:18 EDT
Volume:903.61K
Turnover:4.31M
Market Cap:133.15M
PE:-3.07
High:4.90
Open:4.85
Low:4.69
Close:4.71
52wk High:8.74
52wk Low:3.71
Shares:27.86M
Float Shares:27.23M
Volume Ratio:0.80
T/O Rate:3.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5585
EPS(LYR):-1.6715
ROE:-101.07%
ROA:-40.59%
PB:2.50
PE(LYR):-2.86

Loading ...

Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback

TIPRANKS
·
Sep 14

Unicycive Therapeutics Outlines Oxylanthanum Carbonate Program for Hyperphosphatemia in Dialysis Patients

Reuters
·
Sep 10

Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 01

Unicycive Therapeutics price target raised to $15 from $13 at Benchmark

TIPRANKS
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Unicycive Therapeutics price target lowered to $20 from $22 at B. Riley

TIPRANKS
·
Aug 17

Unicycive Therapeutics Posts Corporate Presentation on Kidney Disease Drug Pipeline, Led by OLC for Dialysis Hyperphosphatemia

Reuters
·
Aug 17

Clene Q2 Net Loss Widens on Higher Other Expenses

Reuters
·
Aug 14

Eledon Pharmaceuticals Q2 Net Loss Widens on Warrant Liability Changes

Reuters
·
Aug 14

Unicycive Therapeutics Price Target Cut to $20.00/Share from $22.00 by B. Riley Securities

Dow Jones
·
Aug 13

B. Riley Securities Reaffirms Their Buy Rating on Unicycive Therapeutics (UNCY)

TIPRANKS
·
Aug 13

B. Riley Adjusts Price Target on Unicycive Therapeutics to $20 From $22, Maintains Buy Rating

MT Newswires Live
·
Aug 13

Unicycive Therapeutics Inc : Guggenheim Cuts Target Price to $25 from $37

THOMSON REUTERS
·
Aug 13

Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs

Reuters
·
Aug 13

Unicycive Rises on Narrower Quarterly Loss

Reuters
·
Aug 13

Unicycive Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Unicycive Therapeutics Q2 Net Loss Narrows on Warrant Liability Change

Reuters
·
Aug 12

Unicycive Therapeutics Q2 EPS USD -0.06

THOMSON REUTERS
·
Aug 12

Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 12

Unicycive Therapeutics - Q2 Net Loss was $1.70 Mln or $0.06 Per Share

THOMSON REUTERS
·
Aug 12